[1]
S. Weidinger, M. A. Tollenaere, K. Drerup, T. Litman, and H. Norsgaard, “Atopic dermatitis disease biomarkers strongly correlate with IL-13 levels, are regulated by IL-13, and are modulated by tralokinumab in vitro”, J of Skin, vol. 3, p. S42, Nov. 2019.